Post-WeWork, the Neumanns Are Still Billionaires. Whatever Happened to Their Philanthropy?

Post-WeWork, the Neumanns Are Still Billionaires. Whatever Happened to Their Philanthropy?

Before being forced out of the company, Adam and Rebekah Neumann signaled some big philanthropic aspirations. They’re still very wealthy; did they continue giving?

Read More

A Public-Private Cancer Funder Backs Team Science and Targets Inequities in Care and Outcomes

A Public-Private Cancer Funder Backs Team Science and Targets Inequities in Care and Outcomes

Cancer Grand Challenges has announced $125 million across five new grants to take on key questions in cancer research and to better understand causes of poorer health outcomes for certain patient populations.

Read More

A Foundation’s Long Quest to Take on Huntington’s Disease Picks Up Speed

A Foundation’s Long Quest to Take on Huntington’s Disease Picks Up Speed

The neurodegenerative disease gets less funder attention than other more common conditions, which is why a set of new $1 million research grants from the Hereditary Disease Foundation could really move the needle.

Read More

Backed By Sergey Brin, the Newest Force in Parkinson's Research Looks to Speed Cures

Backed By Sergey Brin, the Newest Force in Parkinson's Research Looks to Speed Cures

Aligning Science Across Parkinson's, established by the Google cofounder, wants to diversify genetic research into the neurodegenerative disease. Its latest big grant will expand the geographic scope of a key international study.

Read More

Five Questions for Alice Pomponio, Head of the American Cancer Society's Impact Investing Arm

Five Questions for Alice Pomponio, Head of the American Cancer Society's Impact Investing Arm

The ACS is the largest nongovernment, nonprofit funder of cancer research in the U.S. We spoke with the head of BrightEdge, its venture capital team, which uses a for-profit model to advance the mission.

Read More

How the Leukemia & Lymphoma Society Is Working to Ensure Equitable Access to Care

How the Leukemia & Lymphoma Society Is Working to Ensure Equitable Access to Care

A top priority for cancer research funders is ensuring that patients receive equitable and timely access to treatment and care. We check in with a leading advocate and grantmaker to see how it’s approaching this work.

Read More

A Quiet Exodus: Funders Exit HIV Giving Even as Equity Gaps Grow

A Quiet Exodus: Funders Exit HIV Giving Even as Equity Gaps Grow

For World AIDS Day, guest authors Athena Cross, Carl Baloney and Jesse Milan Jr. call attention to diminishing HIV-related philanthropic support, despite prevailing racial equity gaps in diagnoses and treatment.

Read More

Paul Allen's Philanthropic Legacy Continues with Funding for a Brand-New Field of Health Research

Paul Allen's Philanthropic Legacy Continues with Funding for a Brand-New Field of Health Research

The late Microsoft co-founder’s Paul G. Allen Frontiers Group has launched its newest Discovery Center. Its goal: exploring how the human nervous system and immune system interact to shape health and disease.

Read More

Progress on Breast Cancer Hasn’t Been Evenly Distributed. This Funder’s on the Case

Progress on Breast Cancer Hasn’t Been Evenly Distributed. This Funder’s on the Case

Tackling demographic disparities in outcomes and care has been a big priority for cancer funders lately. Susan G. Komen, a major backer of breast cancer research, care and advocacy, is no exception.

Read More

Starting With a Big Boost for Rare Disease Research, This Couple Are Ramping Up Their Giving

Starting With a Big Boost for Rare Disease Research, This Couple Are Ramping Up Their Giving

Mike and Sofia Segal came to the U.S. in 1978 from Ukraine with $120 and built a fortune in the electric power industry. Now, they're rolling out a set of big donations, starting with a $17 million gift to fight a rare blood cancer.

Read More

Military Experience Is Less Common Today, But These Funders Are Staying True to Veterans

Military Experience Is Less Common Today, But These Funders Are Staying True to Veterans

Philanthropy for veterans often stems from personal or family experience, making a decline in the percentage of Americans who’ve served a cause for concern. But these veterans-focused funders bucked that trend in 2023.

Read More

A Local Foundation, a Little-Known College, and a Potential HIV and Cancer Breakthrough

A Local Foundation, a Little-Known College, and a Potential HIV and Cancer Breakthrough

The Engelstad Foundation supported Touro University Nevada's lone biomedical lab when few other funders would. A recent discovery there could lead to new treatments for HIV, and even cancer, Alzheimer’s and more.

Read More

Gates Remains Among the Few in Philanthropy to Drive Research for an HIV Vaccine

Gates Remains Among the Few in Philanthropy to Drive Research for an HIV Vaccine

Philanthropy makes up only a small fraction of spending on research and support for people with HIV, still a major threat around the world. In the push for a vaccine, Gates and Gilead are leading the pack.

Read More

After a Tragic Diagnosis, a Former NFL Player and His Wife Rally Support for ALS Research

After a Tragic Diagnosis, a Former NFL Player and His Wife Rally Support for ALS Research

ALS remains a devastating disease, but research is advancing, thanks in large part to the efforts of those impacted. Eric and Amanda Stevens have turned to the athlete and first responder communities to raise awareness and funds.

Read More

Type 1 Diabetes Is an Overlooked Global Threat. This Health Funder Has Made it a Top Priority

Type 1 Diabetes Is an Overlooked Global Threat. This Health Funder Has Made it a Top Priority

Among non-communicable diseases, diabetes has a particularly low profile as a global health concern. The Helmsley Charitable Trust has made it a central focus, including two recent commitments to the WHO.

Read More

A New Big Gift Tackles the Problem of Inflammatory and Immune-Mediated Disease

A New Big Gift Tackles the Problem of Inflammatory and Immune-Mediated Disease

To build up collaborative research infrastructure, a landmark $100 million gift from businessman Gene Lay will launch a new institute spanning Brigham and Women's Hospital, Mass General and Harvard Medical School.

Read More

Report Finds Scant Funding for Disability Rights and Social Justice — and Points the Way Forward

Report Finds Scant Funding for Disability Rights and Social Justice — and Points the Way Forward

A study commissioned by the Disability & Philanthropy Forum is a must-read for funders aiming to drive social justice for disabled people and address complex and overlapping issues of racial, gender and other inequities.

Read More

Can AI Help Locate Low-Cost Cancer Treatments? These Funders Want to Find Out

Can AI Help Locate Low-Cost Cancer Treatments? These Funders Want to Find Out

We can't have too many ways to fight cancer. Here’s who’s backing a nonprofit startup that’s using AI to repurpose generic drugs that could mean the difference between life and death for patients — and solvency or bankruptcy.

Read More

How Effective is Effective Altruism? A Deep Dive Into Two of Open Philanthropy’s EA-Inspired Programs

How Effective is Effective Altruism? A Deep Dive Into Two of Open Philanthropy’s EA-Inspired Programs

Effective altruism has had a rough year, but remains a major force within philanthropy. We take a closer look at two of this EA-driven outfit’s programs: farm animal welfare and biosecurity and pandemic preparedness.

Read More

Why a Relatively Small Funder Made a Big Donation to Study Neglected Diseases

Why a Relatively Small Funder Made a Big Donation to Study Neglected Diseases

The $78 million gift from a foundation built by an heir to the du Pont fortune will fuel research and clinical care for children with cancer, sickle cell disease and other life-threatening blood disorders.

Read More